What if the U.S. adopts price controls on drugs?

In Doug Badger, senior fellow at the Galen Institute, opinion column published by The Daily Signal, writes how according to leaked description of a drug price negotiation bill (H.R. 3) by House Speaker Nancy Pelosi, “would double down on the failures of existing government policies that have contributed to higher health care costs.” Read his views on why this bill is the wrong choice. Click here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.